What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Myocardial infarction
His primary areas of study are Internal medicine, Cardiology, Myocardial infarction, Heart failure and Endocrinology.
His research in Internal medicine intersects with topics in Diabetes mellitus and Surgery.
His Diastole research extends to Cardiology, which is thematically connected.
His Myocardial infarction research is multidisciplinary, incorporating perspectives in Apoptosis, Pathology, Stroke, Stem cell and Transplantation.
The various areas that he examines in his Heart failure study include Type 2 diabetes and Angiotensin Receptor Antagonists.
His Endocrinology course of study focuses on ALDH2 and AMPK, Downregulation and upregulation and Phosphorylation.
His most cited work include:
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (1150 citations)
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction (419 citations)
- Update on Myocardial Bridging (415 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cardiology, Myocardial infarction, Endocrinology and Percutaneous coronary intervention.
His work on Heart failure, Ejection fraction, Coronary artery disease and Randomized controlled trial as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
His Cardiology study integrates concerns from other disciplines, such as Stent and Surgery.
His study involves Mace and ST segment, a branch of Myocardial infarction.
Cell biology is closely connected to Downregulation and upregulation in his research, which is encompassed under the umbrella topic of Endocrinology.
His research is interdisciplinary, bridging the disciplines of Conventional PCI and Percutaneous coronary intervention.
He most often published in these fields:
- Internal medicine (58.89%)
- Cardiology (39.32%)
- Myocardial infarction (18.77%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (58.89%)
- Cardiology (39.32%)
- Myocardial infarction (18.77%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Heart failure.
Much of his study explores Internal medicine relationship to Endocrinology.
His work deals with themes such as Stroke, Proportional hazards model, Blood pressure and Confidence interval, which intersect with Cardiology.
His biological study spans a wide range of topics, including Clinical endpoint and Pharmacology.
The Percutaneous coronary intervention study combines topics in areas such as Stent, Surgery, Conventional PCI and Revascularization.
In the field of Heart failure, his study on Cardiac function curve, Cardiac resynchronization therapy and Cardiac fibrosis overlaps with subjects such as Cause specific.
Between 2019 and 2021, his most popular works were:
- Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes (76 citations)
- Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. (72 citations)
- The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension (46 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Myocardial infarction
His main research concerns Internal medicine, Cardiology, Heart failure, Ejection fraction and Endocrinology.
His studies in Hazard ratio, Blood pressure, Area under the curve, Cohort study and Troponin I are all subfields of Internal medicine research.
The study incorporates disciplines such as Proportional hazards model and Confidence interval in addition to Cardiology.
His research integrates issues of Glucose transporter and Transforming growth factor in his study of Heart failure.
His Ejection fraction research incorporates elements of Aortic valve, Clinical endpoint and Dapagliflozin.
The various areas that Junbo Ge examines in his Endocrinology study include Heat shock protein, AMPK, Evolocumab and Immune system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
